Philips (ADR) (PHG)
Builds clinical imaging, connected-care systems, respiratory equipment, and personal-health devices.
Something off on this page? Send us feedback.
Builds diagnostic imaging, image-guided therapy, patient monitoring and informatics, sleep and respiratory care, and personal-health devices. Revenue comes from Diagnosis & Treatment, Connected Care, and Personal Health, while the Respironics remediation and a federal consent decree continue to shape respiratory-device operations.
Builds diagnostic imaging, image-guided therapy, patient monitoring and informatics, sleep and respiratory care, and personal-health devices across three reportable segments: Diagnosis & Treatment, Connected Care, and Personal Health.
Combines organized research, clinical hardware, connected software, and acquired interventional and monitoring capabilities. The focused health-technology portfolio emerged through acquisitions and the separation of lighting and domestic-appliance operations.
Execution centers on product quality, patient safety, supply reliability, and business-unit accountability. Respironics ventilator remediation remains in progress, while a federal consent decree restricts covered respiratory-device manufacturing and distribution at specified US facilities until regulatory conditions are met.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $2.04B · Total debt $8.51B · Total assets $30.43B · Shareholders' equity $13.05B
- Revenue
- $4.97B
- Operating income
- $695.2M
- Net income
- $437.7M
Reported in EUR, converted at the latest exchange rate
HistoryDividendAnnual yield
| Institutions | 5.36% | 51.58M ADS | |
|---|---|---|---|
| 376 holders · as of Jun 30, 2026 | |||
| Other | 94.64% | 911.34M ADS | |
| remainder | |||
962.92M ADS as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Mondrian Investment Partners LtdInstitution | 0.84% | 8.07M ADS | as of Jun 30, 2026 |
Dimensional Fund Advisors LPInstitution | 0.45% | 4.34M ADS | as of Jun 30, 2026 |
Fiduciary Management Inc /WI/Institution | 0.36% | 3.46M ADS | as of Jun 30, 2026 |
Causeway Capital Management LLCInstitution | 0.32% | 3.06M ADS | as of Jun 30, 2026 |
Morgan StanleyInstitution | 0.30% | 2.94M ADS | as of Jun 30, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
- GE HealthCare
Broad overlap in imaging, ultrasound, monitoring, and hospital software
- ResMed
Direct sleep and respiratory rival in connected home care
- Medtronic
Overlaps in catheter-based therapy devices and acute-care monitoring
- Procter & Gamble
Oral-B and Braun challenge Sonicare and personal-care devices
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Philips (ADR) | $24.58 | −1.58% | $24.41B | 18.9 | 12.8 | 1.2 | −2.8% |
| GE HealthCare | $66.07 | −0.30% | $29.93B | 19.2 | 12.7 | 1.5 | +5.8% |
| ResMed | $222.38 | +0.18% | $32.20B | 21.3 | 18.3 | 5.7 | +8.6% |
| Medtronic | $90.08 | −0.76% | $116.19B | 22.4 | 15.0 | 3.1 | +13.7% |
| Procter & Gamble | $147.42 | −0.54% | $352.35B | 22.4 | 21.1 | 4.0 | +1.5% |
| Median | 21.9 | 16.7 | 3.6 | +7.2% |